• <em>Tsc2</em> shapes olfactory bulb granule cell molecular and morphological characteristics
• A multicenter, matched case-control analysis comparing burden of illness among patients with tuberous sclerosis complex related epilepsy, generalized idiopathic epilepsy, and focal epilepsy in Germany
• A new view of macula densa cell protein synthesis
• A novel role of CRTC2 in promoting nonalcoholic fatty liver disease
• A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex
• Aberrant DJ-1 expression underlies L-type calcium channel hypoactivity in dendrites in tuberous sclerosis complex and Alzheimer's disease
• Aberrant TSC-Rheb axis in Oxytocin receptor+ cells mediate stress-induced anxiety
• Amplification of human interneuron progenitors promotes brain tumors and neurological defects
• An overview of actionable and potentially actionable TSC1 and TSC2 germline variants in an online Database
• Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China
• Angiotensin II receptor type 1 blockade regulates Klotho expression to induce TSC2-deficient cell death
• Aspirin-exacerbated respiratory disease is associated with variants in filaggrin, epithelial integrity, and cellular interactions
• Autosomal dominant genodermatoses in adults being heralded by superimposed skin lesions in children
• Biallelic ELOC-Inactivated Renal Cell Carcinoma: Molecular Features Supporting Classification as a Distinct Entity
• Cancer Predisposition Syndromes in Neuro-oncology
• Case Report: Patent ductus arteriosus with tuberous sclerosis complex
• Case report: The origin of transmantle-like features
• Cerebellar demyelination and neurodegeneration associated with mTORC1 hyperactivity may contribute to the developmental onset of autism-like neurobehavioral phenotype in a rat model
• Clinical characteristics and genetic analysis of a Chinese pedigree affected with tuberous sclerosis complex
• Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cells
• Cortical wiring by synapse type-specific control of local protein synthesis
• Cross talk between LAM cells and fibroblasts may influence alveolar epithelial cell behavior in lymphangioleiomyomatosis
• Cutaneous Angiofibroma
• Cutaneous Angiofibroma
• Dermoscopy of hypopigmented macules unveiling genetic diagnosis of tuberous sclerosis complex type 2 in an infant presenting with sacral chordoma
• Developmental effects of constitutive mTORC1 hyperactivity and environmental enrichment on structural synaptic plasticity and behaviour in a rat model of autism spectrum disorder
• Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex
• Early Post-Natal Immune Activation Leads to Object Memory Deficits in Female <em>Tsc2</em>^+/- Mice: The Importance of Including Both Sexes in Neuroscience Research
• Ectopic HCN4 Provides a Target Biomarker for the Genetic Spectrum of mTORopathies
• Epilepsy severity mediates association between mutation type and ADHD symptoms in tuberous sclerosis complex
• Epilepsy surgery in children with tuberous sclerosis
• Epilepsy Surgery in Young Children With Tuberous Sclerosis Complex: A Novel Hybrid Multimodal Surgical Approach
• Epileptic spasms are associated with increased stereo-electroencephalography derived functional connectivity in tuberous sclerosis complex
• Facial Features of Hereditary Cancer Predisposition
• Familial Neoplastic Syndromes
• Genetics of Pancreatic Neuroendocrine Tumors
• Have epilepsy outcomes changed for children with tuberous sclerosis complex in Queensland, Australia?
• High-Resolution Proteomics Unravel a Native Functional Complex of Cav1.3, SK3, and Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels in Midbrain Dopaminergic Neurons
• Identification of an Electrogenic 2Cl(-)/H(+) Exchanger, ClC5, as a Chloride-Secreting Transporter Candidate in Kidney Cyst Epithelium in Tuberous Sclerosis
• Identification of an Electrogenic 2Cl^-/H⁺ Exchanger, ClC5, as a Chloride-Secreting Transporter Candidate in Kidney Cyst Epithelium in Tuberous Sclerosis
• Identification of serum and glucocorticoid-regulated kinase 1 as a regulator of signal transducer and activator of transcription 3 signaling
• Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesions
• Increased susceptibility to kainate-induced seizures in a mouse model of tuberous sclerosis complex: Importance of sex and circadian cycle
• Interictal and seizure-onset EEG patterns in malformations of cortical development: A systematic review
• Investigating the Prevalence, Gender Predilection, and Inheritance Patterns of Genodermatoses: A Tertiary Hospital Study
• Jagged-1 is induced by mTOR inhibitors in renal cancer cells through an Akt/ALK5/Smad4-dependent mechanism
• Kidney collecting duct cell type composition is regulated by Notch signaling via modulation of mTORC1
• LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination
• Long-term dietary DHA intervention prevents telomere attrition and lipid disturbance in telomerase-deficient male mice
• Loss of <em>TSC1/TSC2</em> sensitizes immune checkpoint blockade in non-small cell lung cancer
• Low-frequency electroacupuncture improves disordered hepatic energy metabolism in insulin-resistant Zucker diabetic fatty rats via the AMPK/mTORC1/p70S6K signaling pathway
• Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity
• Managing Headache Disorders Associated with Tuberous Sclerosis and Neurofibromatosis
• Mechanistic Target of Rapamycin Complex 1 Signaling Links Hypoxia to Increased IGFBP-1 Phosphorylation in Primary Human Decidualized Endometrial Stromal Cells
• Modeling tuberous sclerosis complex with human induced pluripotent stem cells
• MR Imaging Detection of CNS Lesions in Tuberous Sclerosis Complex: The Usefulness of T1WI with Chemical Shift Selective Images
• mTOR Pathway Somatic Pathogenic Variants in Focal Malformations of Cortical Development: Novel Variants, Topographic Mapping, and Clinical Outcomes
• Multidisciplinary neurocutaneous syndrome clinics: a systematic review and institutional experience
• Multidisciplinary Outpatient Clinic of Neurocutaneous Diseases: Five-year Experience of a Pediatric Tertiary Hospital in Portugal
• Nervous system (NS) Tumors in Cancer Predisposition Syndromes
• Neurocutaneous Disorders in Pregnancy
• Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden
• Neurodevelopmental Findings and Epilepsy in Malformations of Cortical Development
• Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies
• Neurofibromatosis Type 1
• Neurofibromatosis Type 1
• Neurofibromatosis type1, type 2, tuberous sclerosis and Von Hippel-Lindau disease
• Orbital Perivascular Epithelioid Cell Tumor in a Case of Tuberous Sclerosis
• Overview of therapeutic options for epilepsy
• Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification
• Pediatric cervical kyphosis in the MRI era (1984-2008) with long-term follow up: literature review
• Perinatal adversities in tuberous sclerosis complex: Determinants and neurodevelopmental outcomes
• Periplaneta americana extract CⅡ-3 induces senescence of leukemia K562 cells via SIRT1/mTOR signaling pathway
• Perivascular Epithelioid Cell-Family Tumors in Children, Adolescents and Young Adults:Clinicopathologic Features in 70 Cases
• Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis
• Phosphorylation of PBX2, a novel downstream target of mTORC1, is determined by GSK3 and PP1
• Prdx5 in the Regulation of Tuberous Sclerosis Complex Mutation-Induced Signaling Mechanisms
• Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). I. Drugs in preclinical and early clinical development
• Prophylactic Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Embolization of Renal Angiomyolipoma: A Comparative Study
• Refractive Errors, Retinal Findings, and Genotype of Tuberous Sclerosis Complex: A Retrospective Cohort Study
• Regulation of TSC2 lysosome translocation and mitochondrial turnover by TSC2 acetylation status
• Rescue of impaired blood-brain barrier in tuberous sclerosis complex patient derived neurovascular unit
• Role of Type I Interferon Signaling and Microglia in the Abnormal Long-term Potentiation and Object Place Recognition Deficits of Male Mice With a Mutation of the Tuberous Sclerosis 2 Gene
• Second-line cannabis therapy in patients with epilepsy
• Solitary atrial Rhabdomyoma in an infant with tuberous sclerosis: a case report and review of the literature
• Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia
• Syndroms associated with benign skin tumors
• Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease
• Taylor's focal cortical dysplasia revisited: History, original specimens and impact
• The microbiota-dependent tryptophan metabolite alleviates high-fat diet-induced insulin resistance through the hepatic AhR/TSC2/mTORC1 axis
• The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata
• The therapeutic potential of purified cannabidiol
• Transition readiness in adolescents and young adults with chronic genetic skin conditions
• Tsc2 mutation rather than Tsc1 mutation dominantly causes a social deficit in a mouse model of tuberous sclerosis complex
• TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling
• Tuberous Sclerosis, Type II Diabetes Mellitus and the PI3K/AKT/mTOR Signaling Pathways-Case Report and Literature Review
• Tumor Syndromes: Neurosurgical Evaluation and Management
• Tyrosine Kinase Inhibitors Diminish Renal Neoplasms in a Tuberous Sclerosis Model Via Induction of Apoptosis
• Vascular endothelial growth factor-C modulates cortical NMDA receptor activity in cortical lesions of young patients and rat model with focal cortical dysplasia
• Whole Exome Sequencing in a Series of Patients with a Clinical Diagnosis of Tuberous Sclerosis Not Confirmed by Targeted TSC1/TSC2 Sequencing